85 related articles for article (PubMed ID: 25997253)
1. Vitamin D3 enhances antitumor activity of metformin in human bladder carcinoma SW-780 cells.
Guo LS; Li HX; Li CY; Zhang SY; Chen J; Wang QL; Gao JM; Liang JQ; Gao MT; Wu YJ
Pharmazie; 2015 Feb; 70(2):123-8. PubMed ID: 25997253
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor activity of vitamin D3 combined with metformin in human breast carcinoma MDA-MB-231 cells involves m-TOR related signaling pathways.
Guo LS; Li HX; Li CY; Zhang SY; Chen J; Wang QL; Gao JM; Liang JQ; Gao MT; Wu YJ
Pharmazie; 2015 Feb; 70(2):117-22. PubMed ID: 25997252
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D3 potentiates the growth inhibitory effects of metformin in DU145 human prostate cancer cells mediated by AMPK/mTOR signalling pathway.
Li HX; Gao JM; Liang JQ; Xi JM; Fu M; Wu YJ
Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):711-7. PubMed ID: 25903858
[TBL] [Abstract][Full Text] [Related]
4. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
Zhang T; Wang X; He D; Jin X; Guo P
Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
[TBL] [Abstract][Full Text] [Related]
5. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
6. Combined use of vitamin D3 and metformin exhibits synergistic chemopreventive effects on colorectal neoplasia in rats and mice.
Li W; Wang QL; Liu X; Dong SH; Li HX; Li CY; Guo LS; Gao JM; Berger NA; Li L; Ma L; Wu YJ
Cancer Prev Res (Phila); 2015 Feb; 8(2):139-48. PubMed ID: 25416412
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits proliferation and proinflammatory cytokines of human keratinocytes in vitro via mTOR-signaling pathway.
Liu Y; Yang F; Ma W; Sun Q
Pharm Biol; 2016 Jul; 54(7):1173-8. PubMed ID: 26305116
[TBL] [Abstract][Full Text] [Related]
8. [Effect of metformin on proliferation and apoptosis of rat prolactinoma MMQ cells and related mechanisms].
Jin K; Ruan L; Pu J; Zhong A; Wang F; Tan S; Huang H; Mou J; Yang G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):643-648. PubMed ID: 28502303
[TBL] [Abstract][Full Text] [Related]
9. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
[TBL] [Abstract][Full Text] [Related]
10. The antidiabetic drug metformin inhibits the proliferation of bladder cancer cells in vitro and in vivo.
Zhang T; Guo P; Zhang Y; Xiong H; Yu X; Xu S; Wang X; He D; Jin X
Int J Mol Sci; 2013 Dec; 14(12):24603-18. PubMed ID: 24351837
[TBL] [Abstract][Full Text] [Related]
11. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
[TBL] [Abstract][Full Text] [Related]
12. hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells.
Wang Q; Luo C; Wu X; Du H; Song X; Fan Y
J Urol; 2013 Nov; 190(5):1912-8. PubMed ID: 23669565
[TBL] [Abstract][Full Text] [Related]
13. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models.
Zi FM; He JS; Li Y; Wu C; Yang L; Yang Y; Wang LJ; He DH; Zhao Y; Wu WJ; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
Cancer Lett; 2015 Jan; 356(2 Pt B):443-53. PubMed ID: 25305450
[TBL] [Abstract][Full Text] [Related]
14. The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway.
Li B; Takeda T; Tsuiji K; Kondo A; Kitamura M; Wong TF; Yaegashi N
Gynecol Endocrinol; 2013 Jan; 29(1):87-90. PubMed ID: 22835064
[TBL] [Abstract][Full Text] [Related]
15. [Lily polysaccharide 1 enhances the effect of metformin on proliferation and apoptosis of human breast carcinoma cells].
Hou J; Li F; Li X; Mei Q; Mi M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):780-3. PubMed ID: 27371846
[TBL] [Abstract][Full Text] [Related]
16. [Proliferation apoptotic influence of crocin on human bladder cancer T24 cell line].
Zhao P; Luo CL; Wu XH; Hu HB; Lv CF; Ji HY
Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(15):1869-73. PubMed ID: 19007019
[TBL] [Abstract][Full Text] [Related]
17. [Growth inhibition of combined pathway inhibitors on KRAS mutated non-small cell lung cancer cell line].
Li ZW; Yang ZL; Feng HL; Bian XC; Liu YY; Liu YQ
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):330-5. PubMed ID: 24004591
[TBL] [Abstract][Full Text] [Related]
18. Effects of metformin on proliferation and apoptosis of human megakaryoblastic Dami and MEG-01 cells.
Liang X; Kong P; Wang J; Xu Y; Gao C; Guo G
J Pharmacol Sci; 2017 Sep; 135(1):14-21. PubMed ID: 28927780
[TBL] [Abstract][Full Text] [Related]
19. High efficacy of intravesical treatment of metformin on bladder cancer in preclinical model.
Peng M; Su Q; Zeng Q; Li L; Liu Z; Xue L; Cheng Y; Huang Y; Tao T; Lv H; Li X; Tao X; Guo P; Chen AF; Yang X
Oncotarget; 2016 Feb; 7(8):9102-17. PubMed ID: 26802022
[TBL] [Abstract][Full Text] [Related]
20. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
